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Background: This study aims to evaluate the prognostic value of high-sensitivity CRP during 10-year follow-up after percutaneous coronary 
intervention (PCI) with drug eluting stent (DES) implanation.
methods: Between April and October 2002, high-sensitivity CRP was measured in 468 consecutive all-comer patients who underwent PCI with DES 
implantation for stable coronary artery disease or acute coronary syndrome. Primary endpoint was 10-year all-cause mortality. Secondary endpoint 
was 10-year incidence of major adverse cardiac events (MACE), defined as all-cause mortality, myocardial infarction or coronary revascularization. 
results: Mean age of the study population was 61.1 years and 69.4% were men. Patients with CRP levels of >3 mg/L (n=215) were more likely to 
be women (p=0.023) and to have a history of diabetes (p=0.012), smoking (p=0.002) and previous myocardial infarction (p<0.001) compared to 
those with CRP levels of ≤3 mg/L (n=253). Cumulative incidence of 10-year all-cause mortality and MACE were 24.9% and 50.1% respectively. After 
adjustment for established cardiovascular risk factors and indication for PCI, CRP levels of >3 mg/L were associated with higher all-cause mortality 
(HR 2.08, 95%CI 1.38-3.15, p=0.001) and higher incidence of MACE (HR 1.36, 95%CI 1.03-1.79, p=0.029).
conclusion: CRP levels >3 mg/L are predictive for adverse cardiovascular outcome, in particular for mortality. The survival curves displayed 
ongoing divergence until 10 years after PCI.
 
